Darrin Miles - Chief Commercial Officer, Agios Pharmaceuticals, Inc

As of May 18, 2021


Darrin Miles Net Worth

  • Net worth is estimated to be at least $873.58K
  • Owns at least 7,209 units of Agios Pharmaceuticals, Inc stock
  • Sold an estimated value of $321.7K in the last 3 months at Agios Pharmaceuticals, Inc

Darrin Miles Trading

  • Largest sale of shares was 3,462 units , worth over $191.83K on May 18, 2021
  • In total has made about 5 transactions over 3 months
  • Usually trades in February, with the busiest year in 2021
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Darrin Miles Mailing Address

  • Mailing address is C/o Agios Pharmaceuticals, Inc. 88 Sidney Street Cambridge MA 02139 MA

Agios Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Jacqualyn A. Fouse, Ph.D. 2020 $746,750 - $1,751,340 $4,593,651 $509,657 $10,577 $7,611,975
Jacqualyn A. Fouse, Ph.D. 2019 $664,583 - $2,538,474 $12,875,608 $424,125 $105,204 $16,607,994
Jacqualyn A. Fouse, Ph.D. 2018 - - - - - - -
Jonathan Biller 2020 $500,000 - - - $258,750 $10,578 $769,328
Jonathan Biller 2019 $39,583 $110,000 $1,008,334 $2,025,036 - $936 $3,183,889
Jonathan Biller 2017 - - - - - - -
Christopher Bowden, M.D. 2020 $515,007 - $618,120 $1,508,875 $243,341 $9,203 $2,894,546
Christopher Bowden, M.D. 2019 $490,539 - $915,590 $1,609,989 $198,668 $12,422 $3,227,208
Christopher Bowden, M.D. 2018 $467,141 - $641,025 $1,746,517 $262,767 $11,280 $3,128,730
Bruce Car, Ph.D. 2020 $494,318 - $833,301 $1,499,943 $236,250 $164,231 $3,228,043
Bruce Car, Ph.D. 2019 - - - - - - -
Bruce Car, Ph.D. 2018 - - - - - - -
Andrew Hirsch 2020 $361,234 - $618,120 $1,508,875 - $397,893 $2,886,122
Andrew Hirsch 2019 $500,476 - $1,923,145 $1,609,989 $202,693 $12,528 $4,248,831
Andrew Hirsch 2018 $471,329 - $641,025 $1,746,517 $265,123 $12,864 $3,136,858
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1439222/000119312521110205/d71514ddef14a.htm

Agios Pharmaceuticals, Inc Insider Trading

  • The most recent transaction was 1,777 units sold on June 23, 2021 by Carman Alenson worth over $109.48K
  • In the last 8 years, insiders at Agios Pharmaceuticals, Inc sold an estimated value of $168.51M and bought an estimated value of $171.9M
  • The most active traders are Scott Biller, Chief Scientific Officer,  David Schenkein, Director,  and John Duncan Higgons, Chief Operating Officer
  • Insider trading is most common in June, with the busiest year in 2014

AGIOS PHARMACEUTICALS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1